Leap Therapeutics Ownership | Who Owns Leap Therapeutics?

Leap Therapeutics Ownership Summary

Leap Therapeutics is owned by 33.34% institutional investors, 16.21% insiders, and 50.45% retail investors. 683 capital management is the largest institutional shareholder, holding 3.50% of LPTX shares. Simplify Health Care ETF is the top mutual fund, with 2.02% of its assets in Leap Therapeutics shares.

LPTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Leap Therapeutics	33.34%	16.21%	50.45%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	307.00%	11.11%	-218.12%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
683 capital management	1.44M	3.50%	$428.76K
Acadian asset management	1.24M	3.00%	$365.00K
Monaco asset management sam	1.05M	2.54%	$311.75K
Simplify asset management	857.36K	2.08%	$254.55K
Key client fiduciary advisors	343.86K	0.83%	$102.09K
Blackrock funding, inc. /de	125.23K	0.30%	$37.18K
Brokers financial services, llc.	44.21K	0.11%	$13.13K
Adar1 capital management	39.92K	0.10%	$11.85K
Drw securities	28.16K	0.07%	$8.36K
Baird financial group	20.00K	0.05%	$5.94K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Monaco asset management sam	1.05M	0.05%	$311.75K
Key client fiduciary advisors	343.86K	0.04%	$102.09K
683 capital management	1.44M	0.03%	$428.76K
Simplify asset management	857.36K	0.01%	$254.55K
Adar1 capital management	39.92K	0.00%	$11.85K
Acadian asset management	1.24M	0.00%	$365.00K
Brokers financial services, llc.	44.21K	0.00%	$13.13K
Xtx topco	14.03K	0.00%	$4.17K
Drw securities	28.16K	0.00%	$8.36K
Federation des caisses desjardins du quebec	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Brokers financial services, llc.	44.21K	0.00%	15.00K
Xtx topco	14.03K	0.00%	14.03K
Raymond james financial	4.58K	-	4.58K
Allworth financial lp	135.00	-	20.00
Drw securities	28.16K	0.00%	-

Top Sellers

Holder	Shares	% Assets	Change
Samsara biocapital	-	-	-2.44M
Point72 asset management	-	-	-1.40M
Rock springs capital management lp	-	-	-1.27M
Laurion capital management lp	-	-	-709.22K
Baker bros. advisors lp	-	-	-404.74K

New Positions

Holder	Shares	% Assets	Change	Value
Xtx topco	14.03K	0.00%	14.03K	$4.17K
Raymond james financial	4.58K	-	4.58K	$1.36K

Sold Out

Holder	Change
Newedge advisors	-82.00
Federation des caisses desjardins du quebec	-500.00
Us bancorp \de\	-610.00
Northwestern mutual wealth management	-1.50K
Cubist systematic strategies	-1.70K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	43	-8.51%	13,760,432	-17.57%	33	2.04%	16	-15.79%	10	-33.33%
Mar 31, 2025	47	-21.67%	16,693,179	-13.67%	40	1.53%	19	-44.12%	15	87.50%
Dec 31, 2024	60	25.00%	19,335,424	31.39%	51	4.04%	34	88.89%	8	-33.33%
Sep 30, 2024	48	-	14,716,283	-0.13%	35	2.52%	18	-30.77%	12	33.33%
Jun 30, 2024	48	4.35%	14,734,903	73.98%	37	3.83%	26	18.18%	9	-10.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Simplify Health Care ETF	837.65K	2.02%	-19.71K
Vanguard US Total Market Shares ETF	754.74K	1.83%	-
Vanguard Total Stock Mkt Idx Inv	738.59K	1.78%	-16.14K
Vanguard Institutional Extnd Mkt Idx Tr	270.89K	0.65%	-123.44K
BIT Biotech Opportunities S	192.30K	0.47%	-
Fidelity Extended Market Index	169.53K	0.41%	-
BlackRock Extended Equity Market K	82.86K	0.22%	-35.00
BIT Global Leaders I - I	81.00K	0.20%	-
Extended Equity Market Fund K	80.38K	0.19%	-1.60K
iShares Micro-Cap ETF	61.84K	0.15%	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	-

LPTX Ownership FAQ

Who Owns Leap Therapeutics?

Leap Therapeutics shareholders are primarily institutional investors at 33.34%, followed by 16.21% insiders and 50.45% retail investors. The average institutional ownership in Leap Therapeutics's industry, Biotech Stocks , is 307.00%, which Leap Therapeutics falls below.

Who owns the most shares of Leap Therapeutics?

Leap Therapeutics’s largest shareholders are 683 capital management (1.44M shares, 3.50%), Acadian asset management (1.24M shares, 3.00%), and Monaco asset management sam (1.05M shares, 2.54%). Together, they hold 9.04% of Leap Therapeutics’s total shares outstanding.

Does Blackrock own Leap Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Leap Therapeutics.

Who is Leap Therapeutics’s biggest shareholder by percentage of total assets invested?

Monaco asset management sam is Leap Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 1.05M Leap Therapeutics shares, valued at 311.74K$.

Who is the top mutual fund holder of Leap Therapeutics shares?

Simplify Health Care ETF is the top mutual fund holder of Leap Therapeutics shares, with 2.02% of its total shares outstanding invested in 837.65K Leap Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools